SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-262034
Filing Date
2018-08-29
Accepted
2018-08-29 16:44:21
Documents
39
Period of Report
2018-08-29

Document Format Files

Seq Description Document Type Size
1 6-K d606011d6k.htm 6-K 13526
2 EX-99.1 d606011dex991.htm EX-99.1 180014
3 EX-99.2 d606011dex992.htm EX-99.2 92111
4 EX-99.3 d606011dex993.htm EX-99.3 70494
11 GRAPHIC g606011g35h71.jpg GRAPHIC 3997
  Complete submission text file 0001193125-18-262034.txt   1522675

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT asnd-20180630.xml EX-101.INS 198198
6 XBRL TAXONOMY EXTENSION SCHEMA asnd-20180630.xsd EX-101.SCH 21107
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20180630_cal.xml EX-101.CAL 34469
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20180630_def.xml EX-101.DEF 56286
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20180630_lab.xml EX-101.LAB 162000
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20180630_pre.xml EX-101.PRE 118741
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 181044752
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1